Biologics
-
Biologics
OssDsign AB Further Strengthens its Patent Portfolio
Newest additions are related to the company's material technology and implant design.OssDsign AB 07.22.19
-
Biologics
SeaSpine Expands Portfolio of OsteoStrand and OsteoStrand Plus Demineralized Bone Fibers
The first OsteoStrand Plus implantations were conducted in Maryland.Globe Newswire 07.19.19
-
Biologics | Materials
New Hydrogel Could Help Regenerate Cartilage
Polymer material has the capacity to generate the appropriate niche for growth in a number of chondrocytes.University of Granada 07.10.19
-
Biologics
Anika Appoints Executive Vice President of Business Development and Strategic Planning
Industry veteran brings extensive experience leading business development groups.Business Wire 07.09.19
-
Biologics
NanoFUSE Biologics Continues Global Expansion With Launch in Thailand
Thailand is one of the fastest aging countries in Asia and is well-known for medical tourism.PR Newswire 07.08.19
-
Biologics | Spine/Neurology
Celling Spine Buys Link Spine
With this acquisition, Celling intends to further develop and promote a cell-centric spine platform.PR Newswire 07.02.19
-
Biologics
Private Equity Firm Purchases Axolotl Biologix
Company plans to initiate clinical trials and FDA product approvals.Axolotl Biologix Inc. 06.27.19
-
Biologics
Demand for User-friendly, Versatile Bone Growth Stimulators to Create Multiple Market Opportunities
The global bone growth stimulators market is expected to account for $1.38 billion by the end of 2029, research shows.Future Market Insights 06.26.19
-
Biologics
Cerapedics Appoints Vice President of Clinical and Market Development
New hire most recently served as director of Market Development for Spinal Kinetics, an Orthofix Company.PR Newswire 06.25.19
-
Biologics | Materials
Hydrogel Offers Double Punch Against Bone Infections
Hydrogel showed reduction in Staphylococcus aureus infection—a common infection in orthopedic surgery—along with regeneration within large bone defects.Georgia Tech 06.24.19
-
Biologics
Study: Regulations Limit Orthopedic Biomaterials Across U.S., European Markets
Biomaterials increasingly are becoming popular with patients who want to avoid surgical implantation of permanent devices or hardware.Business Wire 06.18.19
-
Biologics | Trauma/Sports
Ortho RTi Welcomes New CEO
Claude LeDuc has spent 22 years in the musculoskeletal market, having occupied senior positions with Genzyme, Biomatrix, Serono, and BioSyntech.PR Newswire 06.17.19
-
Biologics | Large Joint
Bioventus & MTF Biologics to Develop Next-Gen Placental Tissue Product for Knee Arthritis
There is a promising and growing body of evidence underscoring the potential of these preparations in supporting the body’s natural healing processes.Business Wire 06.07.19
-
Biologics | Large Joint | Materials
Nitric Oxide-Scavenging Hydrogel Could Treat Rheumatoid Arthritis
Rheumatoid arthritis occurs when nitric oxide (NO) is overproduced in the body.Pohang University of Science & Technology (POSTECH) 06.05.19
-
Biologics
FDA OKs EpiBone to Begin First-In-Human, Phase 1/2 Trial of Stem Cell-Derived Bone Graft
EB-CMF is a living anatomically correct bone graft manufactured from a patient's own adipose-derived stem cells.PR Newswire 05.29.19
-
Biologics
The ABCs of HCT/Ps
Navigating the complex regulatory pathway of human cell and tissue products.Lindsay Kleinwaks, Ph.D., Associate, Regulatory Affairs, MCRA 05.23.19
-
3-D Printing/Additive Mfg. | Biologics | Extremities | Materials
A Little Extreme: Factors Impacting the Extremities Implants Segment
3D printing, surgical planning, and innovations that simplify procedures increasingly are shaping the global extremities market.Michael Barbella, Managing Editor 05.23.19
-
Biologics | Bracing/Prosthetics
The Changing World Around Orthopedic Implants
Those who have been in this industry for more than a few years realize implant technology has not changed all that much. Sure, there are new product releases offering innovative benefits not previously available. Further, emerging manufacturing techn…Sean Fenske, Editor-in-Chief 05.23.19
-
Biologics
SINTX and EU Consortium Collaborate on Silicon Nitride Development
Silicon nitride offers the mechanical strength, chemical stability, and biocompatibility needed to manufacture spinal implants.Globe Newswire 05.21.19
-
Biologics
Parametrics Medical Partners with DePuy Synthes to Provide Allografts for Sports Medicine Repairs
Agreement supports Parametrics’ and DePuy Synthes’ shared commitment to a comprehensive sports medicine procedural focus.Parametrics Medical Inc. 05.16.19
